Forbes

Eli Lilly: 50% Upside For LLY Stock?

On Thursday, August 7, Eli Lilly's stock (NYSE:LLY) dropped by 14%, even though the company announced a strong quarter with earnings, revenues, and guidance that exceeded market expectations. This ...
24/7 Wall St.

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two ...
Forbes

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...
Reuters

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet

March 31 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it would buy ‌Centessa Pharmaceuticals (260y.F), opens new tab in a deal valued at up to $7.8 billion as the U.S. drugmaker looks ...
AOL

Eli Lilly's $12.8 billion obesity bet faces new Medicare test

That is why the size of Lilly's obesity-drug business is important to investors. Mounjaro earned almost $8.7 billion in sales in the first quarter of 2026, with Zepbound accounting for approximately ...